7.40
price up icon0.00%   0.00
after-market Handel nachbörslich: 7.43 0.03 +0.41%
loading

Finanzdaten der Kezar Life Sciences Inc-Aktie (KZR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
11.71
- 17.63 21.56 21.95
Operating Income/Loss
-11.71
- -17.63 -21.56 -21.95
Income/Loss From Continuing Operations Before Tax
18.08%
-11.23
-13.70 -16.56 -20.22 -20.31
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.08%
-11.23
-13.70 -16.56 -20.22 -20.31
Net Income/Loss
18.08%
-11.23
-13.70 -16.56 -20.22 -20.31
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
7.3231
- 7.3057 0.00328 7.2962
Diluted Average Shares
7.3231
- 7.3057 0.00328 7.2962
Basic Earnings Per Share
-1.53
- -2.27 -2.77 -2.78
Diluted Earnings Per Share
-1.53
- -2.27 -2.77 -2.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):